By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Huntingdon Life Sciences 

P.O. Box 2360
Mettlers Road
East Millstone  New Jersey  08875  U.S.A.
Phone: 732-873-2550 Fax: 732-873-3992


Huntingdon Life Sciences is one of the world's largest contract research organizations, providing a comprehensive range of non-clinical development services for the Pharmaceutical, Biotechnology, Industrial Chemical, Agrochemical, Food and Veterinary industries.

As well as its world-renowned expertise in the testing of small molecule drugs, HLS has considerable experience in developing biopharmaceuticals, having tested a diverse range of products including recombinant proteins, monoclonal antibodies, vaccines, gene and cell therapies, antisense products and conventional biologics.

With a testing facility in the US and two in the UK, we have over 1400 staff worldwide and fifty years of experience in the design and implementation of testing programs.

Resources offered cover all aspects of pre-clinical research and development including:

  • Pre-Clinical Lead Optimization Technologies to aid candidate selection
  • Discovery Pharmacology and Efficacy testing
  • Toxicology / Pathology
  • Immunopharmacology and Immunotoxicology
  • Immunohistochemistry
  • Metabolism, Pharmacokinetics, Tissue Distribution and Bioanalysis
  • Assay Development and Validation
  • Biochemistry, Molecular Biology, Virology, Hematology, Microbiology, Drug Screening and Histology
  • Routine and Specialized Routes of Delivery including infusion and inhalation
  • Safety Pharmacology
  • Genetic Toxicology
  • Reproductive Studies
  • Pharmaceutical Analysis, Stability Testing and GMP batch release

    HLS has alliances with Phase I clinics and these partnerships, together with the assistance of our Regulatory Affairs colleagues for the preparation of regulatory documentation, allow us to take lead candidates from early development through to clinical testing. This integrated process is managed by our dedicated Program Management Group who ensure that the most appropriate data is obtained to a high, regulatory acceptable standard within the shortest time frame, allowing rapid entry to clinic. Our expert consultancy teams provide the best quality advice and can support our customers during discussions with regulatory agencies.

    For further details, please contact us at:

    Tel: +1 (732) 873-2550
    Fax: +1 (732) 873-3992

    Tel: +44 (0) 1480 892000
    Fax: +44 (0) 1480 892250

    Tel: +81 (0) 3 3238 6381-7
    Fax: +81 (0) 3 3238 6388-9

    Last Updated: 03-04-04

    Key Statistics

    Ownership: Private

    Web Site: Huntingdon Life Sciences

  • Industry

    Company News
    Huntingdon Life Sciences Release: The Changing Face Of Non-Clinical Development – How Contract Research Organizations Are Adapting Service Offerings To Provide Customers With Increased Understanding Of Drug Mechanism Of Action On Safety Studies 9/9/2015 2:41:45 PM
    Huntingdon Life Sciences And Harlan Laboratories, Inc. Announce New Equity Funding 7/17/2015 11:42:13 AM
    Huntingdon Life Sciences And Harlan Laboratories, Inc. To Become Envigo 6/24/2015 11:50:24 AM
    Huntingdon Life Sciences And Harlan Laboratories, Inc. Appoints Corporate Vice President For Global Strategic Marketing 5/27/2015 12:31:18 PM
    Huntingdon Life Sciences And Harlan Laboratories, Inc. Announce The Launch Of The SHrN™ Novel Hairless NOD.SCID Model At AACR 2015 4/20/2015 9:09:07 AM
    Huntingdon Life Sciences And Harlan Laboratories, Inc. Announce Joint Presence At SOT 2015 3/23/2015 12:13:43 PM
    Huntingdon Life Sciences And Harlan Laboratories, Inc. To Operate Under New Brand And Name 2/24/2015 10:40:15 AM
    Up to 95 Jobs Cut at Huntingdon Life Sciences 2/14/2013 8:25:35 AM
    Up to 100 Jobs to Go at Huntingdon Life Sciences as Another Round of Redundancies Announced Before Christmas 12/12/2012 7:54:06 AM
    Huntingdon Life Sciences Announces Expansion Of Pre-Clinical Pharmaceutical Inhalation Facility In U.S.10/19/2005 5:13:12 PM